press center press release

NASDAQ OMX Welcomes Dehaier Medical Systems to The NASDAQ Stock Market


NEW YORK, April 26, 2010 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ), the world's largest exchange company, announced that the trading of Dehaier Medical Systems, commenced Thursday, April 22, 2010 on The NASDAQ Stock Market and trades under the ticker symbol (Nasdaq:DHRM).

"We are thrilled to have Dehaier Medical Systems among our 131 listed companies from Greater China, more than is listed on any other U.S. exchange," said Bruce Aust, Executive Vice President, Corporate Client Group, NASDAQ OMX.

"As the 25th IPO this year on NASDAQ, Dehaier Medical Systems joins the successful IPO of China Lodging Group (Nasdaq:HTHT). China Lodging Group raised $110 million, making it the largest Chinese IPO in the U.S. so far this year," he added.

Chinese listings included the IPOs of China Electric Motor (Nasdaq:CELM) and Andatee China Marine Fuel Services (Nasdaq:AMCF) as well as over-the-counter upgrades of SinoCoking & Coke Chemical Industries (Nasdaq:SCOK), Subaye (Nasdaq:SBAY) and China Recycling Energy Corp. (Nasdaq:CREG).


The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries.  NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit *Please follow NASDAQ OMX on Facebook ( and Twitter (

About Dehaier Medical Systems:

A developer and manufacturer of respiratory and oxygen home care equipment, the company offers more than 30 products, including ventilators, sleep breathing therapy and screening systems (to ease or monitor snoring and other sleep disorders), and oxygen concentrators. Its non-core medical devices offerings include vitals monitors, anesthesia machines, and X-ray machines. Dehaier sells products in China through a network of about 2,000 distributors and operates more than two dozen offices that cover the country's 32 provinces; it also sells directly to hospitals, clinics, and consumers, to a lesser extent. Dehaier was founded in 1991.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein may contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to, factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

Neither The NASDAQ OMX Group, Inc., nor any of its affiliates (collectively "NASDAQ OMX"), makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investors should undertake their own due diligence and carefully evaluate companies before investing.


CONTACT: The NASDAQ OMX Group, Inc. Media Contact: Jolene Libretto (646) 441-5220

In This Story


Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more